Scott L Burrows
CIK 1853327 · Chief Financial Officer · last filed 2026-06-03
Scott L Burrows is a Chief Financial Officer who has filed 20 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for SYRE, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.82M
3
20
-$3.02M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRE | Chief Financial Officer | 103,693 | $80.79 | $8.38M | -$2.72M | 10 | 2026-06-03 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Chief Financial Officer | — | $12.01 | — | $0 | 1 | 2023-09-05 |
| ARQT | Chief Financial Officer | 59,115 | $24.38 | $1.44M | -$298.6K | 9 | 2023-03-08 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | SYRE | Mixed | — | -$424.2K | EDGAR |
| 2026-05-01 | SYRE | Mixed | — | -$710.9K | EDGAR |
| 2026-04-03 | SYRE | Mixed | — | -$261.3K | EDGAR |
| 2026-03-03 | SYRE | Mixed | — | -$65.4K | EDGAR |
| 2026-01-13 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2025-09-03 | SYRE | Sell (S) | −18,428 | -$299.6K | EDGAR |
| 2025-01-17 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2024-09-05 | SYRE | Sell (S) | −18,531 | -$522.1K | EDGAR |
| 2024-02-02 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2023-12-22 | SYRE | Grant (A) | +134,953 | $0 | EDGAR |